Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

The document concludes that skin and nail changes can indicate various underlying health conditions.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

Wrinkles, dry skin, and hair changes are common in elderly skin, while infections and eczema are also prevalent.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Tattoos may trigger autoimmune symptoms in some people.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

A runner developed tangled armpit hairs from shirt friction, preventable by shaving or wearing smooth shirts.

Recognizing skin symptoms can help diagnose and manage COVID-19.

New therapies show promise for wound healing, but more research is needed for safe, affordable options.

Fungal infections are the most common skin issue in the region.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Physical activity, height, and smoking affect prostate cancer risk.

Antibiotics often cause skin reactions, making them a major health concern.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Brazilian patients with inflammatory bowel disease have a high rate of skin problems compared to healthy people.

COVID-19 can cause or worsen skin conditions and might show early signs of infection.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

RDW can be a useful marker for inflammation in alopecia areata patients.

Athletes need effective management of skin disorders for their performance and well-being.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The model and estimator can predict drug exposure in kidney transplant patients well.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.